$XE

Centrica, X-energy Advance Nuclear Plans as UK Regulators to Begin Design Review for Xe-100, (but with a warning)

Centrica and X-energy announced the UK's acceptance of X-energy's Xe-100 reactor design into the Generic Design Assessment. The process, expected to take 3 years, is a step toward commercial licensing. The companies plan to deploy up to 6 GW of new nuclear capacity in the UK. X-energy highlighted potential risks in its SEC filings.

Original reporting
Published Sep 18, 2026, 4:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 4:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Centrica, X-energy Advance Nuclear Plans as UK Regulators to Begin Design Review for Xe-100, (but with a warning) — source image
Decision brief

The 30-second read

$XEBullishMed
01

Why it matters

The announcement provides fresh, material information that could shift XE's valuation as the company moves closer to market entry.

02

Market read

Regulatory progress for a US‑listed nuclear SMR developer could influence sector sentiment and attract capital to advanced nuclear projects.

03

What to watch

Funding requirements and supply‑chain constraints for SMR deployment may temper growth expectations.

Relevance 7/10Novelty 8/10Timing: same‑day announcement

Background

X-energy (Nasdaq: XE) partners with Centrica to develop up to 6 GW of Xe‑100 SMRs in the UK. The UK regulator's acceptance into the Generic Design Assessment marks the first formal step toward commercial deployment.

Company-level read

Ticker impact

$XEBullishHigh confidence
Context

X-energy's Xe-100 reactor was accepted into the UK Generic Design Assessment, a first regulatory step toward commercial licensing.

Expected impact

Potential upside as investors price in future UK contracts.

Evidence & confidence

The GDA acceptance is a material, first‑report regulatory milestone for a listed SMR developer.

Market effects

Advances SMR and nuclear‑energy sector outlook, may benefit peers pursuing UK licences.

Supports UK clean‑energy targets and could attract further investment in domestic nuclear projects.

Signals growing trans‑Atlantic collaboration on advanced nuclear technology.

Counterpoint

Regulatory timelines remain uncertain; UK approvals could face delays, limiting near‑term upside.

Key entities

  • X-energy, Inc.

    Developer of the Xe‑100 advanced SMR, listed on Nasdaq (XE).

  • Centrica plc

    UK energy firm partnering with X‑energy on SMR deployment.

  • UK Office for Nuclear Regulation

    Administers the Generic Design Assessment process.

Related articles

$OKLOMedAI 8/10

OKLO, XE Stocks Jump After-Hours — Trump Administration Taps Oklo, X-Energy In $200M Push To Power AI Data Centers

Oklo Inc. (OKLO) and X-Energy Inc. (XE) gained in after-hours trading after joining a $200M federal initiative to build nuclear power plants for AI data centers. The program includes Microsoft (MSFT) and Nvidia (NVDA), with $60M allocated to labs and universities. The initiative aims to accelerate reactor construction and reduce staffing needs, addressing rising electricity demand and grid strain.

$OKLOHigh

Nuclear Stocks Oklo, NuScale Power, and X

Shares of Oklo (OKLO), NuScale Power (SMR), and X-Energy (XE) surged after the U.S. House passed the Ratepayer Protection Act, which may boost demand for their small modular reactors as data center power sources. XE stock rose 12.08% to $16.33. Analysts see 106% upside for XE, with a $33.71 average price target.

$OKLOMed

Why Did Nuclear Stocks OKLO, SMR, NNE, LEU, XE Jump On Thursday?

U.S. nuclear stocks surged after the House passed the Ratepayers Protection Act, which shifts power upgrade costs to data centers. Oklo (OKLO) rose 11%, NuScale (SMR) gained 9%, Nano Nuclear (NNE) up 8.5%, Centrus (LEU) rose 8%, and X-Energy (XE) closed 12% higher. The bill may boost demand for nuclear power solutions for AI data centers.

$XEMed

X-energy Xe-100 Reactor Accepted Into UK Nuclear Regulatory Review

Centrica (LSE:CAN) and X-Energy (NASDAQ:XE) announced the Xe-100 small modular reactor has entered the UK's Generic Design Assessment process, a regulatory review expected to take three years. The partnership aims to deploy up to 6 GW of new nuclear capacity, potentially involving 10-20 reactors. The Xe-100 can produce 80 MW of electricity or 200 MW of thermal energy. X-energy is also developing projects in the US with Dow Inc. and Energy Northwest.